Aurobindo Pharma Ltd. announced that its board of directors has approved a proposal to merge Eugia Steriles Private Limited and Eugia SEZ Private Limited, both wholly owned step-down subsidiaries, with Eugia Pharma Specialities Limited, a wholly owned subsidiary, through a Scheme of Amalgamation to be filed with the National Company Law Tribunal in Hyderabad. The amalgamation, which is intended to simplify the group structure and create synergy benefits, involves companies engaged in the manufacturing of injectable pharmaceutical products, with Eugia Pharma reporting a turnover of Rs 27,259.04 million for the financial year ended March 31, 2026, Eugia Steriles Rs 62.7 million, and Eugia SEZ Rs 4,874.2 million.
